{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:40:26Z","timestamp":1775616026916,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T00:00:00Z","timestamp":1538179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Municipal Administration of Hospitals\u2019 grant for the Development of Clinical Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12876-018-0869-9","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T06:45:57Z","timestamp":1538203557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Wen","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-6688","authenticated-orcid":false,"given":"Calvin Q.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,29]]},"reference":[{"issue":"1","key":"869_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cld.2016.08.007","volume":"21","author":"H Saithanyamurthi","year":"2017","unstructured":"Saithanyamurthi H, Faust AJ. Drug-induced liver disease: clinical course. Clin Liver Dis. 2017;21(1):21\u201334.","journal-title":"Clin Liver Dis"},{"issue":"45","key":"869_CR2","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.3748\/wjg.v16.i45.5651","volume":"16","author":"F Bessone","year":"2010","unstructured":"Bessone F. Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage? World J Gastroenterol. 2010;16(45):5651\u201361.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"869_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1034\/j.1600-0676.2000.020001093.x","volume":"20","author":"S Laurent","year":"2000","unstructured":"Laurent S, Rahier J, Geubel AP, Lerut J, Horsmans Y. Subfulminant hepatitis requiring liver transplantation following ibuprofen overdose. Liver. 2000;20(1):93\u20134.","journal-title":"Liver"},{"issue":"6","key":"869_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.trsl.2010.01.005","volume":"155","author":"Radu M. Nanau","year":"2010","unstructured":"Nanau RM, Neuman MG. Ibuprofen-induced hypersensitivity syndrome. Transl Res. 2010;155:275\u201393.","journal-title":"Translational Research"},{"issue":"2","key":"869_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jpeds.2004.05.027","volume":"145","author":"M Taghian","year":"2004","unstructured":"Taghian M, Tran TA, Bresson-Hadni S, Menget A, Felix S, Jacquemin E. Acute vanishing bile duct syndrome after ibuprofen therapy in a child. J Pediatr. 2004;145(2):273\u20136.","journal-title":"J Pediatr"},{"issue":"3","key":"869_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ajg.2016.08.006","volume":"17","author":"A Basturk","year":"2016","unstructured":"Basturk A, Artan R, Yilmaz A, Gelen MT, Duman O. Acute vanishing bile duct syndrome after the use of ibuprofen. Arab J Gastroenterol. 2016;17(3):137\u20139.","journal-title":"Arab J Gastroenterol"},{"issue":"3","key":"869_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3349\/ymj.2014.55.3.834","volume":"55","author":"HY Kim","year":"2014","unstructured":"Kim HY, Yang HK, Kim SH, Park JH. Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant. Yonsei Med J. 2014;55(3):834\u20137.","journal-title":"Yonsei Med J"},{"issue":"8","key":"869_CR8","first-page":"1626","volume":"91","author":"I Alam","year":"1996","unstructured":"Alam I, Ferrell LD, Bass NM. Vanishing bile duct syndrome temporally associated with ibuprofen use. Am J Gastroenterol. 1996;91(8):1626\u201330.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"869_CR9","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.28967","volume":"65","author":"HL Bonkovsky","year":"2017","unstructured":"Bonkovsky HL, Kleiner DE, Gu J, Odin JA, Russo MW, Navarro VM, Fontana RJ, Ghabril MS, Barnhart H, Hoofnagle JH. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements. Hepatology (Baltimore, Md). 2017;65(4):1267\u201377.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"869_CR10","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1177\/030089161309900426","volume":"99","author":"K Nader","year":"2013","unstructured":"Nader K, Mok S, Kalra A, Harb A, Schwarting R, Ferber A. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature. Tumori. 2013;99(4):e164\u20138.","journal-title":"Tumori"},{"issue":"1","key":"869_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1742-7843.2009.00474.x","volume":"106","author":"D Juricic","year":"2010","unstructured":"Juricic D, Hrstic I, Radic D, Skegro M, Coric M, Vucelic B, Francetic I. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man. Basic Clin Pharmacol Toxicol. 2010;106(1):62\u20135.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"nov28 1","key":"869_CR12","doi-asserted-by":"publisher","first-page":"bcr2014208117","DOI":"10.1136\/bcr-2014-208117","volume":"2014","author":"M. Mason","year":"2014","unstructured":"Mason M, Adeyi O, Fung S, Millar BA. Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma. BMJ Case Rep. 2014. https:\/\/doi.org\/10.1136\/bcr-2014-208117 .","journal-title":"Case Reports"},{"issue":"9","key":"869_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1592\/phco.30.9.953","volume":"30","author":"AL Schumaker","year":"2010","unstructured":"Schumaker AL, Okulicz JF. Meropenem-induced vanishing bile duct syndrome. Pharmacotherapy. 2010;30(9):953.","journal-title":"Pharmacotherapy"},{"issue":"7","key":"869_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1177\/0883073809343474","volume":"25","author":"S Gokce","year":"2010","unstructured":"Gokce S, Durmaz O, Celtik C, Aydogan A, Gulluoglu M, Sokucu S. Valproic acid-associated vanishing bile duct syndrome. J Child Neurol. 2010;25(7):909\u201311.","journal-title":"J Child Neurol"},{"issue":"4 Pt 1","key":"869_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/0016-5085(92)90780-3","volume":"102","author":"GM Forbes","year":"1992","unstructured":"Forbes GM, Jeffrey GP, Shilkin KB, Reed WD. Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome. Gastroenterology. 1992;102(4 Pt 1):1385\u20138.","journal-title":"Gastroenterology"},{"issue":"6","key":"869_CR16","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1097\/MPG.0b013e31823c2500","volume":"55","author":"H Bhayana","year":"2012","unstructured":"Bhayana H, Appasani S, Thapa BR, Das A, Singh K. Lamotrigine-induced vanishing bile duct syndrome in a child. J Pediatr Gastroenterol Nutr. 2012;55(6):e147\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"869_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0016-5085(98)70154-4","volume":"115","author":"M Srivastava","year":"1998","unstructured":"Srivastava M, Perez-Atayde A, Jonas MM. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology. 1998;115(3):743\u20136.","journal-title":"Gastroenterology"},{"issue":"5","key":"869_CR18","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/MPG.0b013e3182a95951","volume":"57","author":"Y Kawasaki","year":"2013","unstructured":"Kawasaki Y, Matsubara K, Hashimoto K, Tanigawa K, Kage M, Iwata A, Nigami H, Fukaya T. Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis. J Pediatr Gastroenterol Nutr. 2013;57(5):e30\u20131.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"60","key":"869_CR19","doi-asserted-by":"publisher","first-page":"102640","DOI":"10.18632\/oncotarget.21123","volume":"8","author":"HH Zhong","year":"2017","unstructured":"Zhong HH, Hu SJ, Yu B, Jiang SS, Zhang J, Luo D, Yang MW, Su WY, Shao YL, Deng HL, et al. Apoptosis in the aging liver. Oncotarget. 2017;8(60):102640\u201352.","journal-title":"Oncotarget"},{"issue":"4","key":"869_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5223\/pghn.2013.16.4.273","volume":"16","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Jwa HJ, Kim KS, Gang DY, Kim JY. Ursodeoxycholic acid therapy in a child with trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome. Pediatr Gastroenterol Hepatol Nutr. 2013;16(4):273\u20138.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"22","key":"869_CR21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4254\/wjh.v8.i22.924","volume":"8","author":"K Nemes","year":"2016","unstructured":"Nemes K, Aberg F, Gylling H, Isoniemi H. Cholesterol metabolism in cholestatic liver disease and liver transplantation: from molecular mechanisms to clinical implications. World J Hepatol. 2016;8(22):924\u201332.","journal-title":"World J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0869-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-018-0869-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-018-0869-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:59:32Z","timestamp":1720648772000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-018-0869-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1186\/s12876-018-0869-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,29]]},"assertion":[{"value":"17 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our Institutional IRB approved the case report. The consent to participate is not applicable in the current case report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"142"}}